Thursday, November 17, 2016
Print Current Session:
|
|
Thursday
SESSION 55:
NEW AND IMPROVED DEVICES FOR EVAR AND JUXTARENAL AAA REPAIR (4 ½ Minute Talks)
Moderators:Kenneth Ouriel, MD, MBA / William D. Jordan Jr., MD
|
|
SESSION 55 SCHEDULE | |
6:40 AM - 6:45 AM | The CHAP Project (Characterization Of Human Aortic Anatomy Project): How Well Are Current EVAR Devices Able To Deal With Patient Diversity |
Presenter(s):Thomas S. Maldonado, MD | |
View Slides in PDF | |
6:45 AM - 6:50 AM | AAA Sac Compressibility After EVAR: A New Way To Detect Or Rule Out Endoleaks: How To Determine It With Contrast Enhanced Ultrasound (Duplex) |
Presenter(s):Henrik Sillesen, MD, DMSc | |
6:50 AM - 6:55 AM | EVAR Durability Up To 14 Years With The Cook Zenith Flex AAA Endograft |
Presenter(s):Fabio Verzini, MD, PhD | |
View Slides in PDF | |
6:55 AM - 7:00 AM | The Cook Zenith Alpha AAA Endograft System: Advantages, Limitations And 1-Year Results |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Slides in PDF | |
7:00 AM - 7:05 AM | The Spider Hybrid Graft Device: A New Innovative Way To Treat TAAAs: Concept, Advantages And Early Experience |
Presenter(s):Sebastian E. Debus, MD, PhD | |
View Slides in PDF | |
7:05 AM - 7:10 AM | Clinical Results With The Cordis Incraft Endograft Device For EVAR: Advantages And Limitations |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD | |
View Slides in PDF | |
7:10 AM - 7:15 AM | Panel Discussion |
Moderator(s): Hence J.M. Verhagen, MD, PhD / Nicholas J.W. Cheshire, MD | |
7:15 AM - 7:20 AM | Long-Term (5-8 Years) Results With The Lombard Aorfix Graft And 3-Year Results With The Improved Intelliflex Delivery System: How It Works |
Presenter(s):Mahmoud B. Malas, MD, MHS / Mark F. Fillinger, MD / Andrew Holden, MBChB | |
View Slides in PDF | |
7:20 AM - 7:25 AM | Update On The ARCHYTAS Registry Results With The Lombard Aorfix Endograft Used In Unfavorable Anatomy |
Presenter(s):Vicente Riambau, MD, PhD | |
View Slides in PDF | |
7:25 AM - 7:30 AM | Update On The World Experience With The Ovation Endograft For EVAR: From TriVascular And Now Endologix |
Presenter(s):Patrick Peeters, MD | |
View Slides in PDF | |
7:30 AM - 7:35 AM | Single Center Experience With The Ovation Endograft (TriVascular/Endologix) For EVAR: Advantages, Limitations And Use With Chimney Grafts |
Presenter(s):Venkatesh G. Ramaiah, MD | |
View Slides in PDF | |
7:35 AM - 7:40 AM | Can Polymer Sealing Technology With The Ovation Endograft Treat Short Necked AAAs As Well As Fenestrated And Chimney Grafts: What Are The Limitations |
Presenter(s):David J. Minion, MD | |
View Slides in PDF | |
7:40 AM - 7:45 AM | Aortic Neck Evolution After EVAR With The Ovation Endograft: Does It Dilate As With Other Self-Expanding Endografts |
Presenter(s):Francesco Setacci, MD | |
View Slides in PDF | |
7:45 AM - 7:50 AM | Panel Discussion |
Moderator(s): Keith D. Calligaro, MD / Ali F. AbuRahma, MD | |
7:50 AM - 7:55 AM | Advantages And Limitations Of Lombard’s Altura Endograft Device To Simplify EVAR Procedures: A Multicenter Study |
Presenter(s):David Murray, FRCS | |
View Slides in PDF | |
7:55 AM - 8:00 AM | Early Clinical Results With The Actively Conformable Gore Excluder (CEXC) EVAR Device For AAAs With Severely Angulated Necks: Concept And Advantages |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
View Slides in PDF | |
8:00 AM - 8:05 AM | US Experience With The Gore Iliac Branch Device (IBD) Excluder To Preserve Hypogastric Flow: Advantages, Limitations And Tips For Use |
Presenter(s):Darren B. Schneider, MD | |
View Slides in PDF | |
8:05 AM - 8:10 AM | Results With The Cook Zenith IBD To Preserve Hypogastric Flow: The PRESERVE II Trial And A Ten-Year European Experience: Advantages And Limitations |
Presenter(s):W. Anthony Lee, MD / Fabio Verzini, MD, PhD | |
View Slides in PDF | |
8:10 AM - 8:15 AM | Parallel Grafts Work Very Well For Hypogastric Revascularization If Done Right: Tips For Doing And How They Are More Versatile Than IBDs |
Presenter(s):Armando C. Lobato, MD, PhD | |
View Slides in PDF | |
8:15 AM - 8:20 AM | Panel Discussion |
END OF SESSION 55 | |
previous | next |